Clinical Trials · NCT03591549

Fulvestrant in Metastatic Breast Cancer

Name: Fulvestrant in Metastatic Breast Cancer
Creator: Peptide Science Daily
License: https://clinicaltrials.gov/about-site/terms-conditions

UnknownPhase 4Gonadorelin

Phase: Phase 4
Recruitment status: Unknown
Sponsor: Assiut University
Enrollment: 30
Start date: Aug 2018
Locations: See registry
Primary endpoint: Progression free survival

View Gonadorelin compound reference